Rodeo Therapeutics's competitors

Rodeo Therapeutics's competitors include BlackThorn Therapeutics, Sophiris, Rigel Pharmaceuticals and Caladrius
Add company...
Rodeo Therapeutics
Rodeo Therapeutics is a preclinical-stage biotech company.
BlackThorn Therapeutics
BlackThorn Therapeutics is a clinical-stage biopharmaceutical company
Sophiris
Sophiris is a Canada-based biopharmaceutical company focused on the research, development and commercialization of products for the treatment of urological diseases.
Rigel Pharmaceuticals
Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases.
Caladrius
Caladrius is a biopharmaceutical company developing cellular therapies for the oncology, immunology, and regenerative medicine sectors.
Founding Date
Founding Date
N/A
Founding Date
2013
Founding Date
2002
Founding Date
1996
Founding Date
2006
Type
Type
Private
Type
Private
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Seattle, US HQ
Locations
South San Francisco, US HQ
Locations
San Diego, US HQ
Locations
South San Francisco, US HQ
Locations
Bernards, US HQ
New York, US
Employees
Employees
N/A
Employees
333% decrease
Employees
6
Employees
77
Employees
209
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
105.4 m
Valuation ($)
649.4 m
Valuation ($)
39.8 m
Facebook likes
Facebook likes
N/A
Facebook likes
N/A
Facebook likes
N/A
Facebook likes
1.1 k
Facebook likes
3.7 k
Twitter followers
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
77
Twitter followers
1.3 k
Twitter followers
1.6 k

Financial

Net income
Net income
N/A
Net income
N/A
Net income
($8.6m) (FY, 2017)
Net income
($78m) (FY, 2017)
Net income
$22.2m (FY, 2017)

Funding

Latest funding round
Latest funding round
$ 5.9m (10 months ago)
Latest funding round
$ 14m (over 1 year ago)
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
N/A
Total funding raised
Total funding raised
$ 5.9m
Total funding raised
$ 54m
Total funding raised
$ 47.2m
Total funding raised
$ 130m
Total funding raised
$ 49m
For sources of this data, please see the company profileDownload Excel

View company profiles

BlackThorn Therapeutics
HQ
South San Francisco, US
Employees
33↓ 3% decrease

BlackThorn Therapeutics is a clinical-stage biopharmaceutical company

View company
Sophiris
HQ
San Diego, US
Employees
6

Sophiris is a Canada-based biopharmaceutical company focused on the research, development and commercialization of products for the treatment of urological diseases.

View company
Rigel Pharmaceuticals
HQ
South San Francisco, US
Employees
77

Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases.

View company
Caladrius
HQ
Bernards, US
Employees
209

Caladrius is a biopharmaceutical company developing cellular therapies for the oncology, immunology, and regenerative medicine sectors.

View company